Current issue
Volume 3, Issue 2
Pages no. 39 - 99
Phytosome: Phytolipid Drug Dilivery System for Improving Bioavailability of Herbal Drug
Patel Amit*,Tanwar Y.S., Suman Rakesh, Patel poojan
Formulation Development & Optimization of Immediate Release Tabletoffexofenadine Hydrochloride
Jaimin Modi, Ravindra Kamble, Dr. Chetan Singh Chauhan, Nisarg Patel
Formulation Development and Evaluation of Immediate Release Tablet of Topiramateanti Epileptic Drug
Nisarg patel, Dr.P.S.Naruka,Dr. Chetan Singh Chauhan,Jaimin Modi
The emerging infection of superbug(MRSA) in hospital as well as in community
Harshit A. Jadav
Orodispersible Tablet of Proton Pump Inhibitor Drugs: A Review
Patel Poojan*, Tanwar YS, Jaimin Modi, Amit Patel
Formulation Development and Evaluation of Immediate Release Tablet of Poorly Soluble Candesartan Cilexetil
Shingala Ketan,Dr. Chetan Singh Chauhan, Deepak Dumaniya, Bhavin Patel
Design, Development and Characterization of Immediate Release Tablet of Pioglitazone
Bhavin Patel, Dr. M.S. Ranawat, Dr. Chetan Singh Chauhan, Jaimin Modi
© JPSBR Publications 2011-2024
Powered by Opus
ABSTRACT:
The term superbug is a nonspecific word that is used to describe any microorganism that is resistant to at least one
or more commonly used antibiotics. MRSA is “Methicillin Resistant
Staphylococcus aureus
“is a bacterium that is
resistant to a synthetic penicillin- methicillin. MRSA causes a variety of disseminated, lethal infections in humans.
MRSA has the ability to easily transfer resistant genes to other species directly and indirectly. Overuse of
antibiotics imposes selective pressures which mediates the acquisition of resistance. MRSA has been a major
concern in hospital-based institutions for many years. Now “Community acquired MRSA” has become a health
concern for everyone. 100,000 people are hospitalized each year with MRSA infections. Staph
aureus
bacteria are
commonly carried on the skin or in the noses of healthy people. The one cannot get rid of MRSA; can only control
it.MRSA frequently lives harmlessly on skin surfaces of the mouth, genitalia and rectum. The study showed a 17%
drop in invasive MRSA infections that were diagnosed before hospital admissions (community onset) in people
with recent exposures to healthcare settings.
Keywords:
super bug, MRSA, community, hospital, emerging infection.
ABSTRACT:
Novel Drug Delivery System in the field of medicine had taken a popular attention now aday as it makes the intake,
bioavaibility and overall therapeutics of a drug easier and in short period of time. In current herbal drugs have
been widely used because of their less side effects, cost effectiveness and easy availability. Current review deals
one of the herbal Novel Drug Delivery System i.e. Phytolipid Delivery System. It is also call Phytosome. Phytosomes
are little cell like structure contain the active ingredients of the herb bounded to phospholipids, mainly
phosphatidylcholine. The phospholipid molecular structure includes a water-soluble head and two fat-soluble tails.
Because of this dual solubility, the phospholipids act as an effective emulsifierwhich producing a lipid compatible
molecular complex. Phytosomes are herbal formulation which has enhanced the therapeutic effect of the plant
extracts and herbal lead molecule by increasing bioavaibility in the target site compared to conventional herbal
extract. These drug-phospholipid complexes can be formulated in the form of solution, suspension, emulsion,
syrup, lotion, gel, cream, aqueous microdispersion, capsule, powder, granules and chewable tablet.
Keywords:
Phytosome,Phospholipids, phosphatidylcholine, Bioavaibility.
ABSTRACT:
The investigation was concerned with design and characterization of oral immediate release tablets of Anti allergic drug, in order to
improve efficacy and better patient compliance. The API is selective 2
nd
generation, non sedative, Histamine H1 receptor blocker. The
API has become first line drug in the pharmacotherapy of allergic rhinitis. This is because the drug possesses tolerability and safety
advantages over the Histamine H1 receptor blocker. The aim was to formulate various formulations of immediate release tablet of Anti
allergic drug using different disintegrant and superdisintegrants (Sodium Starch Glycolate, Croscarmellose sodium) and by using
different methods dry granulation and wet granulation. The drug-excipients interaction was investigated by FTIR showed no interaction
of API with excipients. The granules and tablets of API were evaluated for various pre and post compression parameters like Angle of
repose, Compressibility index, Hausner’s ratio, Tablet hardness, Friability, Weight variation, Drug content and
invitro
dissolution. Their
results were found satisfactory. The
invitro
dissolution studies show the release in the following order of superdisintegrants:
Croscarmellose > Sodium Starch Glycolate. Maximum in vitro dissolution was found to be with Formulation F8 and it clearly shows due
to optimum concentration (4%
w/w
) of Croscarmellose sodium and optimum concentration 2.5%w/w povidone. Based on linearity, the
drug release data fit well to Higuchi equation plot (r
2
= 0.915) indicating the diffusion rate limited drug release from tablet formulation.
Drug release mechanism in all media (pH1.2, pH4.0, pH6.8, water) was found as diffusion controlled (i.e., n value- 0.219 to 0.042).
Higuchi square root law which indicates that the drug release follows diffusion release mechanism. Accelerated stability study was
onducted as per ICH guidelines for 1 month. Developed formulation was stable for 1 month as compared to initial and innovator product
from similarity factor f2 of
invitro
drug release study.
Keywords:
Allergic rhinitis, Sodium Starch Glycolate, Croscarmellose sodium.
ABSTRACT:
The most important drug delivery route is undoubtedly the oral route. It offers advantages of convenience of
administration and potential manufacturing cost savings. Drugs that are administered orally, solid oral dosage
forms in general and tablets in particular represent the preferred class of product. Today drug delivery companies
are focusing on solid oral drug delivery systems that offer greater patient compliance and effective dosages. Since
the development cost of a new drug molecule is very high, efforts are now being made by pharmaceutical
companies to focus on the development of new drug dosage forms for existing drugs with improved safety and
efficacy together with reduced dosing frequency and the production of more cost effective dosage forms
.
To fulfill
these medical needs, pharmaceutical technologists have developed a novel oral dosage form known as Orally
Disintegrating Tablets which disintegrate rapidly in saliva without the need to take it with water. In any solid
dosage forms, an important variable is the rate at which the active substance goes into solution or dissolves to
reach the systemic circulation. Dissolution of the active substance is essential for it to be absorbed through the
biological membranes into systemic circulation for eliciting its desired pharmacological activity. The most
important role of a drug delivery system is to get the drug “delivered” to the site of action in sufficient amount and
at the appropriate rate.
Keywords:
Melt in mouth tablet (MMT), orally disintegrating tablets, Proton Pump Inhibitors
ABSTRACT:
The core tablet of topiramate was prepared using wet granulation containing CCS Na,MCC,DPA,Povidone k30.
Opadry White was used for coating the core tablets. Total 16 batches were formulated.In that last 6 batches were
optimized by process parameters like kneading time, lubrication time and by sizing.These formulations were
evaluated for physical parameters of tablet, drug-excipient compatibility study, and in- vitro drug release study.The
optimize formulation F8 release profile was match with marketed formulation and release rate was maximum than
other batches.Stability study of the optimized formulation indicates no significant differences in release profile and
drug content after a period of one to three month.Immediate release dosage form of API was formulated using
Croscarmellose Sodium as superdisintegrant. Among all the formulations, F8 formulation was finally optimized. It is
fulfilling all the parameters satisfactorily. It has shown excellent thickness, hardness, in vitro disintegration and
in
vitro
dissolution.
Keywords:
API ,Croscarmellosesodium,Immediate release, Opadry white.
ABSTRACT:
Candesartan cilexetil is prodrug of candesartan. It is a non-peptide angiotensin П type-І (ATІ) receptor antagonist which is used in the
treatment of hypertension and congestive heart failure. The aim of this research was to formulate a stable as well as robust dosage form.
Candesartan cilexetil show extensive first pass metabolism and less bioavailability. Candesartan cilexetil having low solubility and has
half-life of 9 hrs suggest its suitability for a immediate release formulation. The basic objective was to develop a generic version of anti-
hypertensive tablet in line with the innovator. A generic version of tablet was developed that is safe, efficacious and bioequivalent to the
reference product. The compatibility study of drug with excipients was studied by FTIR spectroscopy. It shows that there was no chemical
interaction between the drug and excipients. Immediate release tablets were prepared by top spray granulation method by using carmellose
calcium as superdisintegrant and PEG as stabilizer and HPC as binder. Prepared tablets showed acceptable IPQC parameters and were
evaluated for
in vitro
drug release. Optimized batch (Batch F10) gave desired results in terms of % drug release after 15-30 min in pH=6.8
and in pH=1.2, it gives <50% release. Similarity factor were calculated for all formulations and it shows that the values of similarity factor (f
2
)
for the batch F010 showed maximum value (89.83 and 73.66 respectively). Stability study of optimized batch was carried out at 45 ± 2
0
C
and 75 ± 5 % RH for one month in a PVDC-PVC aclar blisterpackaing and it was found that there was no statistically significant difference
found in
invitro
drug release before and after stability study.
Keywords: Angiotensin П type-І (ATІ) receptor antagonist, Top spray granulation, Candesartan Cilexetil,
Immediate release tablet,carmellose calcium as superdisintegrant.